{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:14:51Z","timestamp":1782227691440,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88084","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:38:10Z","timestamp":1752676690000},"source":"Crossref","is-referenced-by-count":1,"title":["Adalimumab-Induced Pneumocystis jirovecii Pneumonitis (PCP) Misdiagnosed As Methotrexate-Induced Pneumonitis"],"prefix":"10.7759","author":[{"given":"Shayekh","family":"Ferdoush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Aijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shovan","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustain","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas CF Jr","year":"2004","unstructured":"Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004, 350:2487-98. 10.1056\/NEJMra032588","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2009.02.005","article-title":"Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment","volume":"30","author":"Krajicek BJ","year":"2009","unstructured":"Krajicek BJ, Thomas CF Jr, Limper AH. Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med. 2009, 30:265-78, vi. 10.1016\/j.ccm.2009.02.005","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale SH","year":"1996","unstructured":"Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996, 71:5-13. 10.4065\/71.1.5","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-008-0037-0","article-title":"Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy","volume":"18","author":"Mori S","year":"2008","unstructured":"Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol. 2008, 18:240-6. 10.1007\/s10165-008-0037-0","journal-title":"Mod Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0583-8","article-title":"Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry","volume":"17","author":"Sakai R","year":"2015","unstructured":"Sakai R, Cho SK, Nanki T, et al.. Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry. Arthritis Res Ther. 2015, 17:74. 10.1186\/s13075-015-0583-8","journal-title":"Arthritis Res Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa S","year":"2000","unstructured":"Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J. 2000, 15:373-81. 10.1034\/j.1399-3003.2000.15b25.x","journal-title":"Eur Respir J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon WG","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Symmons DP. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010, 69:1086-91. 10.1136\/ard.2009.120626","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.11.003","article-title":"Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD","volume":"102","author":"Lavorini F","year":"2008","unstructured":"Lavorini F, Magnan A, Dubus JC, et al.. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008, 102:593-604. 10.1016\/j.rmed.2007.11.003","journal-title":"Respir Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis TE","year":"2005","unstructured":"Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005, 41:1232-9. 10.1086\/496922","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz KA","year":"2002","unstructured":"Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002, 34:1098-107. 10.1086\/339548","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"22","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016, 22:2023-38. 10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano J","year":"2017","unstructured":"Rojas-Serrano J, Herrera-Bringas D, P\u00e9rez-Rom\u00e1n DI, P\u00e9rez-Dorame R, Mateos-Toledo H, Mej\u00eda M. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Clin Rheumatol. 2017, 36:1493-500. 10.1007\/s10067-017-3707-5","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4137\/CCRPM.S23286","article-title":"Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations","volume":"9","author":"Mori S","year":"2015","unstructured":"Mori S, Sugimoto M. Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations. Clin Med Insights Circ Respir Pulm Med. 2015, 9:29-40. 10.4137\/CCRPM.S23286","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"ref14","article-title":"Serious infection risk after TNF-alpha inhibitor therapy in rheumatoid arthritis","volume":"367","author":"Dixon WG","year":"2006","unstructured":"Dixon WG, Watson KD, Lunt M, Hyrich KL, Silman AJ. Serious infection risk after TNF-alpha inhibitor therapy in rheumatoid arthritis. Lancet. 2006, 367:1532-7.","journal-title":"Lancet"},{"key":"ref15","article-title":"Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving different immunosuppressive medications","volume":"69","author":"Chen HH","year":"2010","unstructured":"Chen HH, Chen YM, Chen TJ, Chou P, Lan JL. Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving different immunosuppressive medications. Ann Rheum Dis. 2010, 69:1169-73.","journal-title":"Ann Rheum Dis"},{"key":"ref16","article-title":"Clinical characteristics and outcomes of methotrexate-induced pneumonitis in patients with rheumatoid arthritis","volume":"30","author":"Park JW","year":"2009","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim TH. Clinical characteristics and outcomes of methotrexate-induced pneumonitis in patients with rheumatoid arthritis. Rheumatol Int. 2009, 30:929-33.","journal-title":"Rheumatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"98","author":"Camus P","year":"2004","unstructured":"Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respir Med. 2004, 98:459-72. 10.1159\/000079633","journal-title":"Respir Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386725-adalimumab-induced-pneumocystis-jirovecii-pneumonitis-pcp-misdiagnosed-as-methotrexate-induced-pneumonitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:38:12Z","timestamp":1752676692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386725-adalimumab-induced-pneumocystis-jirovecii-pneumonitis-pcp-misdiagnosed-as-methotrexate-induced-pneumonitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.88084","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}